-
Q&A
The FDA’s Risk-Benefit FrameworkUsing the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
Get Involved
Healing Takes FlightAlicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Making Informed Consent Accessible
Confusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Patient and Doctor Partnerships
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors.
by Karon Warren
-
Exploring a New Frontier
AACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Get Involved
The Power of PlayPediatric cancer survivor Eric Newman launched the Roc Solid Foundation, which builds playsets for children who have cancer.
by Thomas Celona
-
Policy Matters
A Call to Eliminate InequitiesThe AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
by Lisa A. Newman, MD, MPH
-
Cultural Competence in the Community
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health Disparities
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff